Full Review of an existing EGP
Full review of an existing EGP, based on value proposition and the respective EGP; feasibility and consistency of the EGP will be evaluated, any evidence gaps will be assessed; includes a targeted review of regulatory and HTA needs, focusing on FDA, EMA, NICE, G-BA and HAS; results are comments in the EGP as well as slides summarizing existing evidence gaps and proposing add-on studies; results of the review will be discussed with the client in a 3-hours virtual workshop.
Timeline: 6-8 weeks
Full review of an existing EGP, based on value proposition and the respective EGP; feasibility and consistency of the EGP will be evaluated, any evidence gaps will be assessed; includes a targeted review of regulatory and HTA needs, focusing on FDA, EMA, NICE, G-BA and HAS; results are comments in the EGP as well as slides summarizing existing evidence gaps and proposing add-on studies; results of the review will be discussed with the client in a 3-hours virtual workshop.
Timeline: 6-8 weeks
Full review of an existing EGP, based on value proposition and the respective EGP; feasibility and consistency of the EGP will be evaluated, any evidence gaps will be assessed; includes a targeted review of regulatory and HTA needs, focusing on FDA, EMA, NICE, G-BA and HAS; results are comments in the EGP as well as slides summarizing existing evidence gaps and proposing add-on studies; results of the review will be discussed with the client in a 3-hours virtual workshop.
Timeline: 6-8 weeks